FDA.reportPublic FDA data

zenocutuzumab-zbco 375 MG per 18.75 ML Injection

RxCUI
2699594
RxNorm name
zenocutuzumab-zbco 375 MG per 18.75 ML Injection
Display name
zenocutuzumab-zbco 375 MG per 18.75 ML Injection
Full name
zenocutuzumab-zbco 375 MG per 18.75 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761352Bizengrizenocutuzumab-zbco351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BIZENGRIZENOCUTUZUMABPartner Therapeutics, Inc.203daea4-fc87-40a4-a92f-ba2351b16de12026-05-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2699594
BIZENGRIZENOCUTUZUMABMerus US, Inc.2a33e782-fc75-4dba-b77c-a44536ac13a52025-01-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2699594

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
203daea4-fc87-40a4-a92f-ba2351b16de1zenocutuzumab-zbco 375 MG per 18.75 ML InjectionSY3These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420260519
203daea4-fc87-40a4-a92f-ba2351b16de118.75 ML zenocutuzumab-zbco 20 MG/ML InjectionSCD3These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420260519
203daea4-fc87-40a4-a92f-ba2351b16de1zenocutuzumab-zbco 375 MG in 18.75 ML InjectionPSN3These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420260519
2a33e782-fc75-4dba-b77c-a44536ac13a518.75 ML zenocutuzumab-zbco 20 MG/ML InjectionSCD2These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420250117
2a33e782-fc75-4dba-b77c-a44536ac13a5zenocutuzumab-zbco 375 MG per 18.75 ML InjectionSY2These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420250117
2a33e782-fc75-4dba-b77c-a44536ac13a5zenocutuzumab-zbco 375 MG in 18.75 ML InjectionPSN2These highlights do not include all the information needed to use BIZENGRI® safely and effectively. See full prescribing information for BIZENGRI. BIZENGRI (zenocutuzumab-zbco) injection, for intravenous use Initial U.S. Approval: 202420250117